Phathom Pharmaceuticals launches DTC campaign for Voquezna, a first-in-class treatment for Erosive Esophagitis and heartburn related to Erosive GERD.
Phathom Pharmaceuticals launches DTC campaign for Voquezna, a first-in-class treatment for Erosive Esophagitis (EE) and heartburn related to Erosive GERD. The campaign, "VOQUEZNA Can Kick Some Acid," is on popular platforms like Prime Video, Hulu, and Peacock, and social media. Voquezna aims to disrupt the stagnant PPI market with its novel therapeutic option, and Phathom offers savings programs for eligible patients.
March 26, 2024
3 Articles